[Seroepidemiology of cholera in Mexico].
Antibodies against Vibrio cholerae were determined in 2352 serum samples obtained from patients with clinical diagnosis of cholera. Samples from their contacts and from healthy people living in the same communities were also analyzed. Vibriocidal antibodies with titers 1:160 or higher were observed in 25% of the samples. An increase of vibriocidal and antitoxin antibody titers were observed in 56 to 60% of the patients in which paired samples were available, one obtained in the acute phase of the disease and the other in the convalescence, confirming the diagnosis of cholera. Differences in the antibody titers were noticed when comparing the serotype according to the geographic area and the season of the year.
González-Bonilla
C
C
Instituto Nacional de Diagnóstico y Referencia Epidemiológicos, México, D.F., Mexico.
Valle-Valdez
J G
JG
Núñez-León
A
A
Moguel-Pech
L
L
Villanueva-Zamudio
A
A
D000208:Acute Disease; D000907:Antibodies, Bacterial / Q000097:blood; D002771:Cholera / Q000453:epidemiology* / Q000382:microbiology; D003289:Convalescence; D004196:Disease Outbreaks; D006801:Humans; D008800:Mexico / Q000453:epidemiology; D015995:Prevalence; D012621:Seasons; D016036:Seroepidemiologic Studies; D012703:Serotyping; D014734:Vibrio cholerae / Q000145:classification / Q000276:immunology
D000907:Antibodies, Bacterial